Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy.
about
As the world grows: contraception in the 21st centuryLeukemia Inhibitory Factor (LIF) Inhibition during Mid-Gestation Impairs Trophoblast Invasion and Spiral Artery Remodelling during Pregnancy in MiceLeukemia inhibitory factor (LIF)STAT3 regulates uterine epithelial remodeling and epithelial-stromal crosstalk during implantationRegulation and function of signal transducer and activator of transcription 3.Activating transcription factor 3 promotes embryo attachment via up-regulation of leukemia inhibitory factor in vitro.IL11 antagonist inhibits uterine stromal differentiation, causing pregnancy failure in mice.Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice.Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.Leukemia inhibitory factor enhances endometrial stromal cell decidualization in humans and miceOsteopontin is expressed in the mouse uterus during early pregnancy and promotes mouse blastocyst attachment and invasion in vitroEgr1 protein acts downstream of estrogen-leukemia inhibitory factor (LIF)-STAT3 pathway and plays a role during implantation through targeting Wnt4.Physiological and molecular determinants of embryo implantationContraceptive vaccines targeting factors involved in establishment of pregnancy.Changes in receptivity epithelial cell markers of endometrium after ovarian stimulation treatments: its role during implantation windowBirth control vaccine targeting leukemia inhibitory factor.High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples.Paeonia lactiflora Enhances the Adhesion of Trophoblast to the Endometrium via Induction of Leukemia Inhibitory Factor Expression.Blocking Endogenous Leukemia Inhibitory Factor During Placental Development in Mice Leads to Abnormal Placentation and Pregnancy LossInterleukin-11 alters placentation and causes preeclampsia features in mice.Leukemia inhibitory factor promotes human first trimester extravillous trophoblast adhesion to extracellular matrix and secretion of tissue inhibitor of metalloproteinases-1 and -2Uterine deletion of Gp130 or Stat3 shows implantation failure with increased estrogenic responses.Growth-differentiation factor-8 (GDF-8) in the uterus: its identification and functional significance in the golden hamster.Reproductive component vaccine developments for contraceptive and non-contraceptive uses.Deciphering the molecular basis of uterine receptivity.Recent progress toward development of vaccines against conception.High molecular weight polyethylene glycol cellular distribution and PEG-associated cytoplasmic vacuolation is molecular weight dependent and does not require conjugation to proteins.The LIF-mediated molecular signature regulating murine embryo implantation.Leukemia inhibitory factor: roles in embryo implantation and in nonhormonal contraception.
P2860
Q24648373-3954F587-679B-4468-8D64-89E1E07FF76FQ27304902-EF9446CA-8E37-4321-89F4-F08F0B83401BQ28082576-9DBF1FE9-AC68-4225-B47A-564E462E1647Q30409357-C83173AB-0B5F-4A9F-A414-E5E802DE7E00Q33728856-E51A9B73-142E-4142-9975-BAA5B67F5891Q33759428-477CA334-57A0-4E95-BAE4-0EF5473FB292Q33770696-11F70A61-DB0B-4151-90AA-CA29444AF920Q33911059-C32C88CF-CA06-4676-8832-F43218C955B1Q33981250-F656E395-B031-4A1F-8210-AC00B29E0095Q34038175-121C12AA-F3DF-4311-836D-08C1BBC9699FQ34061848-2B141BE3-6D0A-481D-9C79-DA91419A1564Q34141081-FCE25E80-DEF2-4DA1-98B6-3771B65A1969Q34320970-5F256A70-03DA-4072-A1CE-DDE5E6282A01Q35032870-6B003606-508E-4D49-8955-B193DAC35547Q35645630-CEF1DA09-5A77-4EAE-8495-BEC6BDC7C9A5Q35681009-3FD7890B-AEA5-4010-BB37-9CED43DF0795Q35755887-DF24CEEE-3DCE-4F1D-BB5F-34C8E5BB7E2FQ35912947-5DAC96F2-3B75-41DD-9D7A-073068462F3CQ35953472-A8BD9017-E66D-4A49-9793-380AF34F71C3Q36435256-7C0300B4-26B9-4719-B27B-1896B9FC4CF2Q36775824-109648E9-F920-4C93-A7CC-8297A6F90F91Q37121418-DA6E5469-0827-45D6-B211-999BD53D2E28Q37465724-0BA4B31B-C42F-431A-B439-D0ED5DA88F29Q37889989-882C11E3-87BB-49F6-8447-3BD757066698Q38052497-F2C81B58-C2CA-4E7D-97FE-0EDCCD91D292Q38168910-0001BFE7-B06C-4BEE-9063-06C253D0B60BQ47227814-FE2955AC-DD1B-4149-B96B-C0C629BE5939Q50648376-18EFEAB4-63BB-49F8-A39B-DE446956170CQ55617573-D0191117-63CD-4590-9C56-F471B272E125
P2860
Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Blocking LIF action in the ute ...... rmonal contraceptive strategy.
@ast
Blocking LIF action in the ute ...... rmonal contraceptive strategy.
@en
type
label
Blocking LIF action in the ute ...... rmonal contraceptive strategy.
@ast
Blocking LIF action in the ute ...... rmonal contraceptive strategy.
@en
prefLabel
Blocking LIF action in the ute ...... rmonal contraceptive strategy.
@ast
Blocking LIF action in the ute ...... rmonal contraceptive strategy.
@en
P2093
P2860
P50
P356
P1476
Blocking LIF action in the ute ...... ormonal contraceptive strategy
@en
P2093
Christine A White
Jian-Guo Zhang
Lorraine Robb
Manuel Baca
P2860
P304
19357-19362
P356
10.1073/PNAS.0710110104
P407
P577
2007-11-27T00:00:00Z